KRT17P3 and non-small cell lung carcinoma: ,130 Collectively, the KRT17P3/miR-497-5p/mTOR regulatory axis affects the chemosensitivity of NSCLC, indicating that this axis represents a promising curative target for NSCLC patients who have developed resistance to cisplatin.